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Abstract
Background: Enterococci are the third most common cause of healthcare-associated infections, which include urinary tract
infections, bacteremia and endocarditis. Cell-surface structures such as lipoteichoic acid (LTA) have been poorly examined in
E. faecalis, especially with respect to urinary tract infections (UTIs). The dlt operon is responsible for the D-alanylation of LTA
and includes the gene dltA, which encodes the D-alanyl carrier protein ligase (Dcl). The involvement of LTA in UTI infection
by E. faecalis has not been studied so far. Here, we examined the role of teichoic acid alanylation in the adhesion of
enterococci to uroepithelial cells.
Results: In a mouse model of urinary tract infection, we showed that E. faecalis 12030DdltA mutant colonizes uroepithelial
surfaces more efficiently than wild type bacteria. We also demonstrated that this mutant adhered four fold better to human
bladder carcinoma cell line T24 compared to the wild type strain. Bacterial adherence could be significantly inhibited by
purified lipoteichoic acid (LTA) and inhibition was specific.
Conclusion: In contrast to bacteraemia model and adherence to colon surfaces, E. faecalis 12030DdltA mutant colonized
uroepithelial surfaces more efficiently than wild-type bacteria. In the case of the uroepithelial surface the adherence to
specific host cells could be prevented by purified LTA. Our results therefore suggest a novel function of alanylation of LTA in
E. faecalis.
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Introduction
Enterococci are the third most common cause of healthcare-
associated infections, which include urinary tract infections,
bacteremia and endocarditis. Risk groups for invasive enterococcal
infections include neonates, Intensive Care Unit (ICU) patients
and immunocompromised hosts [1]. The increasing identification
of enterococcal strains resistant to multiple antibiotics in recent
decades represents a serious threat to therapy and emphasizes the
need for a better understanding of the pathogenicity of these
microbes.
Bacterial adherence is an important step in the disease process
by facilitating colonization and translocation across the mucosal
barrier, which eventually results in systemic dissemination within
the host [2]. Like other Gram-positive bacteria (e.g., Staphylococ-
cus aureus), the surface of E. faecalis is rich in exposed adhesins
that mediate binding to human receptors or to various compo-
nents of the extracellular matrix (ECM); they are thus considered a
member of MSCRAMM-microbial surface component–recogniz-
ing adhesive matrix molecules [3]. Basically, MSCRAMMs are
cell wall–anchored surface proteins that have characteristic
immunoglobulin-like folds [4].
Attachment of microorganisms to mucosal surfaces of the
urinary tract is important for the pathogenesis of UTI, because the
mechanical removal of colonizing bacteria by the urine flow is an
important innate defense mechanism. In the process of bacterial
cell adherence, infectious agents interfere with specific molecules
on epithelial cells [5–6]. Furthermore, it has been shown that the
tendency of certain bacteria to infect specific tissues is often related
to their ability to adhere to a specific target cell.
While UTI-specific virulence factors of E. coli have been studied
extensively, relatively little is known about E. faecalis cell-surface
structures with respect to UTIs [7–10 & 11]. In a model of
ascending UTI, the presence of an enterococcal surface protein
encoded by an acquired gene was shown to increase the
persistence of bacteria in the urinary bladders of mice [7] whereas
[9] demonstrated that E. faecalis has greater tropism for the
kidneys. Using a similar model, the MSCRAMM adhesion of
collagen of E. faecalis (Ace) was recently identified as a putative
virulence factor involved in colonization of renal tissue [12–13]. In
another study, Torelli et al. reported that a PavA-like fibronectin-
binding protein in E. faecalis called enterococcal fibronectin-
binding protein A (EfbA) contributes to the pathogenesis of
enterococcal UTIs. The EfbA mutant shows attenuated colonization
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in a mouse model of mounting UTI [11]. Ebp, a biofilm-associated
pilus, produces immunogenic and pleomorphic pili [14] and also
plays a role in UTI pathogenesis [15].
Generally, the functions of most E. faecalis cell surface
structures have been poorly investigated, especially with respect
to UTIs [7–10,16]. The enterococcal cell wall contains peptido-
glycan (PG) and a number of accessory cell-wall polysaccharides
and glycoconjugates such as LTA wall teichoic acid (WTA), a
rhamnose-containing cell-wall polysaccharide epa (enterococcal
polysaccharide antigen) [17–20] and a diheteroglycan [21].
Lipoteichoic acid (LTA) is an amphiphilic polymer consisting of
polyglycerolphosphate and a glycolipid anchor inserted into the
cell membrane [22–23]. The dlt operon includes four genes and is
responsible for the D-alanylation of LTA [24]. One of these genes,
dltA, encodes the D-alanyl carrier protein ligase (Dcl), which
activates the D-alanine and ligates it to the D-alanyl carrier
protein (Dcp). The involvement of LTA in UTI infection by E.
faecalis has not been studied. Here we examined the role of




T24 human bladder carcinoma cells (Cell Line Service,
Eppelheim, Germany) were cultured in Dulbeccos Modified
Eagles Medium (DMEM, Sigma Aldrich), nutrient mixture F-12
Ham, supplemented with 5% fetal bovine serum (FBS Superior,
Biochrom AG) in a humidified 5% CO2 atmosphere at 37uC.
Bacterial strains and chemicals
E. faecalis 12030 strain is a clinical isolate obtained in
Cleveland, OH. It is a strong biofilm producer and is opsonized
by antibodies against its LTA [25]. E. faecalis 12030DdltA mutant
and its complemented strain E. faecalis 12030DdltAcompl were
kindly provided by C. Theilacker and F. Fabretti. All bacterial
strains were grown at 37uC without agitation in Caso Bouillon
(Carl Roth), and reagents were obtained from Sigma.
LTA extraction
LTA from E. faecalis 12030 wild type were isolated as described
[26] and with modifications by Theilacker et al., 2006 [25].
Bacterial cells were grown in tryptic soy broth, harvested after 3 h
and resuspended in 0.1 M citrate buffer (pH 4.7). The harvested
cells were disrupted using glass beads (Beadbeater; Glenn Mills,
Clifton, NJ) and stirred with an equal volume of n-butanol for
30 min at room temperature. After centrifugation, the aqueous
layer was dialyzed against 0.1 M ammonium acetate (pH 4.7) and
lyophilized. The material was redissolved in 15% n-propanol in
0.1 M ammonium acetate (pH 4.7) and applied to an octyl
Sepharose column for hydrophobic interaction chromatography.
Bound material was eluted with a gradient of 15–80% n-propanol.
Fractions were assayed for total phosphorus and by immunoblot
assay [26].
Invasion/Adherence assay
For the adherence assay, cells were cultivated in 24-well plates
to a density of approximately 16105 cells/well for 16 h. Bacteria
were inoculated at (OD600 nm , 0.1) and grown to mid-log phase
(OD600 nm , 0.4) at 37uC in Caso Bouillon. T24 cells were
incubated with bacteria for 2 h at a multiplicity of infection of
100:1. After infection of the monolayer, human bladder carcinoma
cells were washed five times with bovine serum albumin (PBS,
Biochrom AG) and lysed with DMEM F-12 Ham + 5% FBS +
0.25% Triton-X100 buffer for 15 min. Surface adherent and
intracellular bacteria were enumerated by quantitative bacterial
counts. Six replicates (wells) of each stimulation were prepared and
the full experiment was repeated 3 times.
Inhibition assays
For inhibition of enterococcal binding to T24 cells, purified
LTA (10–500 mg/mL) from wild type E. faecalis 12030 was added
to the cells 30 min before infection. The assay was then performed
as described above.
Mouse Urinary Tract Infection model
Female BALB/C mice (6–8 weeks old, Charles River, Sulzfeld,
Germany) were used for the experiments. To prepare the
inoculum, bacteria were grown in 5 mL for , 16 h at 37uC with
gentle shaking. For inoculum preparation the overnight culture
was diluted 1:100 in 50 mL fresh medium and grown to an
OD600nm , 0.3 at 37uC with shaking. The cells were pelleted for
10 min (6.0006g at 10uC) and resuspended in half of the volume
of 0.9% saline. Further dilutions were prepared in Caso Bouillon
and then plated to determine the actual inoculum. Before starting
the experiment, the bladder of the mouse was emptied by catheter
(20 mm). Subsequently, isoflurane-anesthetized mice were infected
via urethral catheterization with 100 mL of the bacterial suspen-
sion (3–56108 CFU/mL). After 2 h the same amount of bacteria
was injected again to achieve consistent infection. The urethral
catheter was removed immediately after this step, and all animals
had free access to food and water during the course of study. Mice
were euthanized by CO2 inhalation at 24 h and 48 h after
transurethral challenge. The urinary bladder and kidney pairs
were excised, weighed, and homogenized in 1 mL of 0.9% saline +
0.025% Triton X-100, and dilutions were plated onto Caso Agar
without antibiotics. The CFU/100 mg of bacteria for each tissue
(bladder or kidney) was calculated for each animal.
Statistical analysis
If not stated otherwise, the experiments were repeated three
times. All cell culture tests were made by multigroup comparisons
using ANOVA (PRISM4, GraphPad software). P value less than
0.05 was considered significant. Comparisons among groups were
made using the Mann-Whitney U test. P value less than 0.05 was
considered significant.
Ethics Statement
All animal experiments were performed in compliance with the
German animal protection law (TierSchG). The mice were housed
and handled in accordance with good animal practice as defined
by FELASA and the national animal welfare body GV-SOLAS.
The animal welfare committees of the University of Freiburg
(Regierungspräsidium Freiburg Az 35/9185.81/G-11/118) ap-
proved all animal experiments.
Results
E. faecalis 12030DdltA mutant shows strong adherence
to uroepithelial cells
To investigate the importance of LTA D-alanylation to in vitro
adherence to uroepithelia, we used T24 human bladder cell lines,
E. faecalis 12030DdltA mutant and the wild type E. faecalis
12030. As control, the E. faecalis 12030DdltA complemented
strain was used. As shown in Figure 1a, compared to the wild type
strain (0.66106 CFU/mL), the E. faecalis 12030DdltA mutant
showed up to four fold increased adherence (2.96106 CFU/mL,
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p,0.001) to uroepithelial cells. The complemented mutant strain
E. faecalis 12030DdltAcompl showed a partially restored effect of
the mutation (1.26106 CFU/mL, p,0.001).
Bacterial adherence could be inhibited by purified LTA
To study the specific interaction between bacteria and a still-
unknown receptor, T24 cells were first incubated with 100 mg/mL
purified LTA from wild type E. faecalis 12030 strain to saturate
binding sites and subsequently they were inoculated with bacteria.
As shown in Figure 1b, the E. faecalis 12030DdltA mutant with
LTA treatment showed significantly less adherence
(1.256106 CFU/mL, p,0.01) to the bladder epithelial cell line
as compared to without LTA treatment (2.96106 CFU/mL). In
the wild type, no significant differences in adherence properties
were observed using purified LTA and a dose dependent reduction
of adherence using LTA could also demonstrated in Figure 1c.
E. faecalis 12030DdltA colonizes uroepithelial surfaces
more efficiently than wild type bacteria
To study the effect of lipoteichoic acid on urinary tract
infection, a modified mouse urinary infection model was used
[9]. The wild type strain E. faecalis 12030 and the mutant E.
faecalis 12030DdltA were tested. The bacterial counts in the
bladder and in both kidneys were determined after 24 h and 48 h
of incubation as described elsewhere [9]. As shown in Figure 2
after 24 h, the mutant colonized the bladder (46105 CFU/
100 mg) significantly better compared to the wild type strain
(96103 CFU/100 mg), i.e. up to 1.5 log more bacteria (p,0.001).
This difference in colonization behaviour between mutant and
wild type strains was 2.4 logs higher in kidneys (p,0.001). The
mutant showed 36106 CFU/100 mg tissue compared to wild type
96103 CFU/100 mg. We observed colonization differences
between mutant and wild type strains to bladder and kidney
epithelia after the prolonged incubation time of 48 h. A
statistically significant difference (p,0.05) was observed only in
kidneys. Here the mutant colonized up to 96105 CFU/100 mg
tissue whereas the wild type achieved only 16103 CFU/100 mg.
In fact, the E. faecalis 12030DdltA mutant colonized the kidneys
at both time points considerably better than the wild-type strain.
Discussion
Attachment of microorganisms to mucosal surfaces of the
urinary tract is important for the pathogenesis of UTI because the
mechanical removal of colonizing bacteria by the urine flow is an
important innate defense mechanism. In the process of bacterial
cell adherence, infectious agents interfere with specific molecules
on epithelial cells [17,20,5–6,27,28]. While UTI-specific virulence
factors of E. coli have been studied extensively, relatively little is
known about E. faecalis cell-surface structures with respect to
UTIs [7–10 & 11].
In a model of ascending UTI, the presence of an enterococcal
surface protein was shown to increase the persistence of bacteria in
the urinary bladders of mice without histological changes [7]
whereas Kau et al. demonstrated that E. faecalis has greater
tropism for the kidneys [9]. Using a similar model, the
MSCRAMMs of E. faecalis such as collagen adhesion protein
(Ace) [12–13], PavA-like fibronectin-binding protein (EfbA) [11],
and a biofilm-associated pilus (Ebp) [14,15] contributed to the
pathogenesis of enterococcal UTIs.
The D-Ala-LTA formation racks up several functions, such as
cationic homeostasis maintenance, integration of metal cations
Figure 1. Attachment to T24 cells. (A) E. faecalis 12030 wild type, E. faecalis 12030DdltA mutant and the E. faecalis 12030DdltA complemented
strain were tested for their ability to adhere to and/or invade T24 uroepithelial cells. Bacterial titers in logarithmic scale (log scale). T24 cells were
cultivated in 24-well plates to a density of 16105 cells/well and incubated for 2 h with bacteria grown to mid-log phase (OD600nm , 0.4) at a bacteria-
to-cell ratio of 100:1. Total cell-associated bacteria include surface-adherent and intracellular bacteria. Bars represent average 6 S.E. The E. faecalis
12030DdltA mutant shows strongly increased adherence to uroepithelial cells compared to the wild type (p,0.001). B) Treatment of cells with
purified LTA. E. faecalis 12030 wild type and the E. faecalis 12030DdltA mutant were tested. Concentration of purified LTA was 100 mg/mL. The
adherence to uroepithelial cells was significantly reduced by E. faecalis 12030DdltA mutant (p,0.01) after LTA treatment and no differences were
obtained by wild type strain. In each experiment 6 replicates (wells) of each stimulation were prepared. The full experiment was repeated 3 times.
Multigroup comparisons were made by ANOVA (PRISM4, GraphPad software). P-values of ,0.05 (*), ,0.005 (**) and ,0.0005 (***) were considered
statistically significant. C) Dose-dependent reduction in adhesion using purified LTA. E. faecalis 12030DdltA mutant were tested with increasing
concentrations of LTA (10 – 500 mg/mL).
doi:10.1371/journal.pone.0107827.g001
A Novel Role for D-Alanylation of Lipoteichoic Acid
PLOS ONE | www.plosone.org 3 October 2014 | Volume 9 | Issue 10 | e107827
and inflection of autolytic actions and several other electrome-
chanical properties of the bacterial envelope when the surface of
gram-positive bacteria is exposed to disparate microenvironments.
The cell wall of gram-positive bacteria contains different types of
anionic molecules. Two different teichoic acids are present on the
surface of gram-positive bacteria: lipoteichoic acid (LTA), an
amphiphilic polymer non-covalently inserted into the cellular
membrane, and wall teichoic acid (WTA), covalently linked to the
peptidoglycan of the cell wall. These two molecules are synthesized
by separate biosynthetic pathways that have been well character-
ized in Bacillus subtilis and other gram-positive bacteria [29].
Nevertheless, D-alanyl-ester substituents of WTA originally derive
from LTA and are later transferred to WTA by transacylation. It is
a single dlt operon encoding the genes responsible for the D-
alanine incorporation [30–32].
The dltA operon has been studied in several gram-positive
bacteria revealing an identical organization [33]. Bacteria with
mutations in the dlt operon showed a variety of phenotypic
changes that could be attributed to the resulting charge
modification of their cell surface. The lack of D-alanine esters
resulted in a stronger negative net charge, because D-alanine
esters introduce positively charged groups into the otherwise
negatively charged teichoic acids [34]. In B. subtilis and S. aureus,
the absence of D-alanine has been shown to cause alterations in
the activity of autolytic enzymes [35,36]. Also possible is an altered
host immune response, leading to enhanced proliferation/persis-
tence.
In this work, the E. faecalis 12030DdltA mutant has been
investigated with regard to adherence to T24 bladder carcinoma
cells. Surprisingly, we observed that it displayed more than four-
fold increased adherence to human bladder carcinoma cells
compared to the wild-type strain. We could partially restore this
adherence to 1.3106 CFU/mL using a complemented mutant
strain (Figure 1a). Moreover, using purified LTA it was possible to
significantly inhibit adherence to human bladder cells, demon-
strating the specificity of binding (Figure 1b). A dose dependent
reduction of adherence using LTA could also be demonstrated
(data not shown). Interestingly, in contrast to our previous data,
which showed that the same mutant exhibits less binding to Caco2
colonic epithelial cells than wild-type bacteria, here we obtained
higher adherence to uroepithelial cells [3,25,37]. In addition, these
data are in contrast to previous studies using S. aureus and Listeria
monocytogenes, in which elimination of D-alanylation of LTA
impaired adherence to mammalian cells [38–40].
To assess the relevance of these results and the differences in
vivo, a modified mouse urinary infection model was used; our
results confirmed that the E. faecalis 12030DdltA mutant
colonized the kidneys significantly better than the wild-type strain
after 24 and 48 h (Figure 2). In addition, the mutant colonized the
bladder significantly better after 24 and 48 h albeit the differences
observed at 48 h were not statistically significant. This is assumed
by the fact that E. faecalis usually does not persist in the bladder,
resulting in decrease number of colony counts, because of
clearance of bacteria from the bladder by mechanical forces of
urine flow.
However, the same E. faecalis 12030DdltA mutant demon-
strated less colonization in a mouse sepsis model [37]. This
disparate finding suggests the existence of specific receptors on
bladder and/or uroepithelial cell surfaces. Our results therefore
show that D-alanylation of LTA can decrease adherence to
specific host cells and therefore suggest a novel function of
alanylation of LTA in E. faecalis. Differential expression of the dlt
locus may allow enterococci to adapt to specific ecological niches.
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